Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort
Caroline M Stüven, Tina Herold, Paul Foerster, Julian Klaas, Jakob Siedlecki, Siegfried G Priglinger, Leonie F Keidel, Benedikt Schworm · 2026
Read Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort by Caroline M Stüven, Tina Herold, Paul Foerster, Julian Klaas, Jakob Siedlecki, Siegfried G Priglinger, Leonie F Keidel, Benedikt Schworm (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13518713.txt.
Description
Caroline M Stüven and seven colleagues study photodynamic therapy for central serous chorioretinopathy in a large 2026 real-world cohort. In that condition, fluid collects under the retina and blurs vision. Light-activated drug therapy is a standard choice when fluid persists, yet doctors know little about which patients respond best or whether waiting hurts results.
Their review covered 115 patients treated at one center. Retinal thickness fell clearly after therapy, fluid cleared fully in 51.3 percent of eyes, and vision improved slightly. About 30 percent of eyes saw the fluid return, while repeat therapy helped again. Waiting longer before treatment linked to a weaker thickness response, supporting earlier action.
Catalog record
| CREATOR | Caroline M Stüven, Tina Herold, Paul Foerster, Julian Klaas, Jakob Siedlecki, Siegfried G Priglinger, Leonie F Keidel, Benedikt Schworm |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |